Hennion & Walsh Asset Management, Inc. Bridge Bio Pharma, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 36,169 shares of BBIO stock, worth $1.99 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
36,169
Previous 36,709
1.47%
Holding current value
$1.99 Million
Previous $1.29 Million
21.2%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding BBIO
# of Institutions
410Shares Held
187MCall Options Held
11.3MPut Options Held
1.91M-
Viking Global Investors LP18.6MShares$1.02 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$907 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$730 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$685 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$510 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.16B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...